Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Purple corn extract may help reduce prostate enlargement and inflammation.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Hair loss linked to prostate enlargement; stress and family history important factors.

A mix of Panax ginseng and bee-pollen may help prevent prostate enlargement in rats.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.